Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin

Authors

Keywords

Journal

Volume 22, Issue 2, Pages 136-147

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2010-10-22

DOI

10.1097/cad.0b013e3283406e85

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started